Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /404.html Disallow: /404 Disallow: /500.html Disallow: /500 Disallow: /thank* Sitemap: |
Title | R/R MCL and CLL/SLL Treatment | CALQUENCE® (acalabrutinib) 100 mg tablets | For |
Description | LEADING A NEW ERA IN BTK CALQUENCE® (acalabrutinib) is a BTK inhibitor indicated for the treatment of adult patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or R/R Mantle Cell Lymphoma |
Keywords | N/A |
WebSite | calquencehcp.com |
Host IP | 54.239.174.12 |
Location | United States |
Site | Rank |
US$15,643,993
Last updated: 2023-04-28 21:52:48
calquencehcp.com has Semrush global rank of 676,573. calquencehcp.com has an estimated worth of US$ 15,643,993, based on its estimated Ads revenue. calquencehcp.com receives approximately 1,805,077 unique visitors each day. Its web server is located in United States, with IP address 54.239.174.12. According to SiteAdvisor, calquencehcp.com is safe to visit. |
Purchase/Sale Value | US$15,643,993 |
Daily Ads Revenue | US$14,441 |
Monthly Ads Revenue | US$433,219 |
Yearly Ads Revenue | US$5,198,620 |
Daily Unique Visitors | 120,339 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
calquencehcp.com. | A | 299 | IP: 54.239.174.12 |
calquencehcp.com. | A | 299 | IP: 54.239.174.47 |
calquencehcp.com. | A | 299 | IP: 54.239.174.4 |
calquencehcp.com. | A | 299 | IP: 54.239.174.76 |
calquencehcp.com. | NS | 86400 | NS Record: ns-154.awsdns-19.com. |
calquencehcp.com. | NS | 86400 | NS Record: ns-1775.awsdns-29.co.uk. |
calquencehcp.com. | NS | 86400 | NS Record: ns-979.awsdns-58.net. |
calquencehcp.com. | NS | 86400 | NS Record: ns-1229.awsdns-25.org. |
Toggle navigation FOR US HEALTHCARE PROFESSIONALS ONLY Medical Resources Prescribing Information Patient Website Request Samples Request a Rep CHOOSE INDICATION CLL/SLL R/R MCL FOR US HEALTHCARE PROFESSIONALS ONLY Medical Resources Prescribing Information Patient Website Request Samples Request a Rep CHOOSE INDICATION CLL/SLL R/R MCL R/R MCL APPROVED INDICATIONS KINASE SELECTIVITY DOSING & ADMINISTRATION SUPPORT & RESOURCES SUPPORT & RESOURCES Patient Support Patient Profiles Educational Resources Request a Rep More Hide FOR US HEALTHCARE PROFESSIONALS ONLY Medical Resources Prescribing Information Patient Website Request Samples Request a Rep CHOOSE INDICATION CLL/SLL R/R MCL EXPLORE THE TABLET FORMULATION: NO RESTRICTIONS WITH PPIs 1 > LEADING A NEW ERA IN BTK INHIBITION A next-generation selective BTK inhibitor 2 Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) 1 Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL) 1 Studied in multiple Phase 3 CLL trials with up |
HTTP/1.1 403 Forbidden Server: CloudFront Date: Thu, 21 Oct 2021 21:17:45 GMT Content-Type: text/html Content-Length: 919 Connection: keep-alive X-Cache: Error from cloudfront Via: 1.1 c27b73b84ed8b00262acef150bb27b26.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ORD53-C2 X-Amz-Cf-Id: vNRSuilJ7kaGk5uE2ulUIFYNxJZ3EpC6msMcoXRc47pj7gISjAZJdg== |
Domain Name: CALQUENCEHCP.COM Registry Domain ID: 2117856652_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-04-22T05:09:11Z Creation Date: 2017-04-26T15:15:33Z Registry Expiry Date: 2022-04-26T15:15:33Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1229.AWSDNS-25.ORG Name Server: NS-154.AWSDNS-19.COM Name Server: NS-1775.AWSDNS-29.CO.UK Name Server: NS-979.AWSDNS-58.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T16:20:03Z <<< |